by Paris Brain Institute Credit: Pixabay/CC0 Public Domain Thanks to the collaboration between teams from the AP-HP, the MedTech METAFORA biosystems, the Institute of Molecular Genetics of Montpellier, Cerba Healthcare, and more than 30 investigating centers coordinated by Professor Fanny Mochel at Paris Brain Institute, a reliable and rapid blood test now enables early diagnosis of...
by Brain Chemistry Labs Dr. Rachael Dunlop conducts real-time PCR on microRNA extracted from extracellular vesicles derived from blood samples from ALS patients. Credit: Paul Alan Cox, Brain Chemistry Labs ALS is a rare paralytic neurological disease that can impact people in the prime of life. Delays in receiving a definitive diagnosis can be devastating...
by University of Bristol Concept of how mathematical modeling may be used in the development and deployment of blood-based biomarkers for brain tumors. This figure summarizes the role mathematical modeling could play in blood-based liquid biopsy development and implementation. Credit: Dr Johanna Blee, University of Bristol. University of Bristol research could lead to better detection...
WILEY The current 60% five-year survival rate of individuals with oral squamous cell carcinoma (OSCC)—a type of cancer of the mouth and throat—could be greatly improved if treatments were initiated as early as possible. In a study published in Natural Sciences, researchers used a technology called conductive polymer spray ionization mass spectrometry to screen the blood...
by University of Plymouth Fluorescent microscopic picture of 3D model meningioma. Credit: University of Plymouth A research breakthrough shows that a simple blood test could reduce, or in some cases replace, the need for intrusive surgery when determining the best course of treatment for patients with a specific type of brain tumor. Researchers at the Brain Tumor Research Center of Excellence...
UNIVERSITY OF TEXAS AT DALLAS IMAGE: IN RESEARCH PUBLISHED ONLINE FEB. 19 IN THE JOURNAL SCIENCE ADVANCES, UNIVERSITY OF TEXAS AT DALLAS CHEMIST DR. JIE ZHENG AND HIS COLLEAGUES SHOW HOW GOLD NANOPARTICLES COULD PLAY A KEY ROLE IN A SIMPLE BLOOD TEST TO DETECT ACUTE LIVE CANCER EARLIER THAN CURRENT METHODS. FOUR SAMPLES OF...
